Saliva and remote monitoring of active Cytomegalovirus infection and symptoms during ovarian cancer treatment
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 24-011332
NCT ID: NCT06870539
Sponsor Protocol Number: 24-011332
About this study
The purpose of this project is to determine the feasibility and accuracy of using saliva to remotely monitor CMV infection in individuals receiving treatment for ovarian cancer.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
- Age ≥ 18.
- Ability to read and write in English.
- Diagnosed with ovarian cancer (ovarian, primary peritoneal, fallopian tube)
- Receiving care from providers at the Mayo Clinic.
- Regardless of diseases status, actively receiving treatment for ovarian cancer (frontline, maintenance, progression, recurrence).
Exclusion Criteria:
- Pregnant at the time of study participation.
- Inability to provide informed written consent.
- History of dementia, stroke, brain tumors or other condition which may impair their cognitive functioning.
Note: Other protocol defined Inclusion/Exclusion Criteria may apply.
Eligibility last updated 1/08/2025. Questions regarding updates should be directed to the study team contact.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
Contact |
Rochester, Minn.
Mayo Clinic principal investigator Amanika Kumar, M.D. |
Open for enrollment |
Contact information:
Cancer Center Clinical Trials Referral Office
(855) 776-0015
|
More information
Publications
Publications are currently not available